2026
conference-abstract
OpenAlex
Magdalena Postl, Christina Victoria Isabella Tauber, Valentina Glueck, Mira Maria Gliga et autres
Abstract Background: Complete macroscopic tumor resection estimation as visualized by the surgeon is the foremost prognostic factor in high-grade serous ovarian cancer (HGSOC). Objective measures of postoperative molecular residual disease (MRD) are lacking, including serologic and radiologic evaluation. Tumor-informed circulating tumor DNA …
at, de
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Christina Victoria Isabella Tauber, Fabian Trillsch, Magdalena Postl, Valentina Glueck et autres
5574 Background: Prediction of relapse following firstline treatment in patients (pts) with high-grade serous ovarian cancer (HGSOC) remains a major challenge despite recent advances. Reliable markers for assessment of recurrence risk are urgently needed to tailor treatment strategies with circulating tumor DNA …
de, at
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Valentina Glueck, Christoph Grimm, Magdalena Postl, Christian Brueffer et autres
Background/Objectives: The surgeon’s subjective intraoperative evaluation is the standard of care to assess postoperative residual disease (RD) in advanced epithelial ovarian cancer (EOC). We investigated the feasibility of ctDNA as an objective marker for postoperative RD. Methods: This prospective study included 27 …
at, de, se
(code pays fourni par la source)